Business / Finance RSS Feed - Business / Finance

Zebra Imaging enters into strategic partnership with Zygote Media Group

Zebra Imaging, Inc., the world's foremost provider of 3D holographic visualization technologies announced today a strategic partnership with the Zygote Media Group Inc., the industry leader in high-end 3D anatomy and biomedical models for animation and visual effects, to serve the medical and medical education markets. [More]
Semler revenue up 52% in third quarter 2014

Semler revenue up 52% in third quarter 2014

Semler Scientific, Inc., an emerging medical risk assessment company that develops patented products that assist healthcare providers in monitoring patients and evaluating chronic diseases, today reported financial results for the third quarter and nine months ended September 30, 2014. [More]
Aviv REIT reports net income of $12 million for third quarter 2014

Aviv REIT reports net income of $12 million for third quarter 2014

Aviv REIT, Inc. today reported results for the third quarter ended September 30, 2014. [More]
MiMedx Group revenue up 108% in third quarter 2014

MiMedx Group revenue up 108% in third quarter 2014

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its results for the third quarter ended September 30, 2014. [More]
GNC Holdings' consolidated revenue decreases 2.7% to $656.3 million in Q3 2014

GNC Holdings' consolidated revenue decreases 2.7% to $656.3 million in Q3 2014

GNC Holdings, Inc., a leading global specialty retailer of health and wellness products, today reported its financial results for the quarter and year-to-date periods ended September 30, 2014. [More]
Auxilium Pharmaceuticals reports total revenues of $109.6 million for Q3 2014

Auxilium Pharmaceuticals reports total revenues of $109.6 million for Q3 2014

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced financial results for the third quarter ending September 30, 2014. [More]

KCR adopts Veeva Systems’ cloud-based content management solution to improve operations

KCR, a European Contract Research Organization operating across 19 European countries and in the US, has turned to the cloud in a move to improve cross-functional collaboration and trial operations. KCR will replace the mix of paper and file-share solutions used to manage trial master files with Veeva Systems’ cloud-based content management solution, Veeva Vault. [More]

GE Healthcare launches startup campus Health Innovation Village to help entrepreneurs speed up health tech solutions

Today GE Healthcare officially opens Health Innovation Village, its first health tech startup campus, at its Finnish headquarters with the Minister of Economic Affairs in Finland, Jan Vapaavuori and the Mayor of Helsinki, Jussi Pajunen. [More]
Leica Biosystems signs definitive agreement to purchase Devicor Medical Products

Leica Biosystems signs definitive agreement to purchase Devicor Medical Products

Leica Biosystems, a global leader in anatomic pathology laboratory solutions and instruments, announced today that it has entered into a definitive agreement to acquire Devicor Medical Products, Inc. [More]
Life science investment in Northern England: an interview with Dr Geoff Davison, CEO, Bionow

Life science investment in Northern England: an interview with Dr Geoff Davison, CEO, Bionow

There are a number of challenges, but primarily, it's access to funding. The recent BioCap Conference focussed on the access small businesses have to funding and how that's driven by changes in the market place. [More]
PlasmaTech Biopharmaceuticals inks agreement to commercialize MuGard in Australia, New Zealand

PlasmaTech Biopharmaceuticals inks agreement to commercialize MuGard in Australia, New Zealand

PlasmaTech Biopharmaceuticals, Inc., a biopharmaceutical company advancing patient care in critical areas, has entered into an exclusive license agreement with Norgine B.V., a European specialist pharmaceutical company, for the commercialization of MuGard in Australia and New Zealand. [More]
Cadens Medical Imaging partners with Hisense Medical to launch 2D/3D Univiewer in China

Cadens Medical Imaging partners with Hisense Medical to launch 2D/3D Univiewer in China

Cadens Medical Imaging Inc. a Montreal-based startup company, announced today the conclusion of a multimillion dollar licensing and technological collaboration with Chinese multinational Hisense Medical Co. The announcement was made today in Shanghai during a ceremony presided over by Quebec's Prime Minister, Philippe Couillard, who is conducting an Economic Mission in China on behalf of the Province of Quebec. [More]
Vanda reports total revenues of $14.8 million for third quarter 2014

Vanda reports total revenues of $14.8 million for third quarter 2014

Vanda Pharmaceuticals Inc., today announced financial and operational results for the third quarter ended September 30, 2014. [More]
MinuteClinic enters into clinical collaboration agreement with Lifespan

MinuteClinic enters into clinical collaboration agreement with Lifespan

MinuteClinic, the retail medical clinic of CVS Health, and Lifespan, Rhode Island's largest health system, which includes five partner hospitals and multiple physician groups, announced today that they have entered into a clinical collaboration agreement. [More]

Roper Industries' GAAP revenue increases 7% to $884 million in Q3 2014

Roper Industries, Inc. reported financial results for the third quarter ended September 30, 2014. [More]
CTI BioPharma acquires worldwide rights to tosedostat

CTI BioPharma acquires worldwide rights to tosedostat

CTI BioPharma Corp. today announced that it has acquired worldwide rights to tosedostat through concurrent transactions with Vernalis R&D Limited, the originator of tosedostat, and Chroma Therapeutics Ltd., through which CTI previously held a sublicense with respect to tosedostat in North, Central and South America. [More]
MPI Research announces acquisition of Jasper Clinical Research & Development

MPI Research announces acquisition of Jasper Clinical Research & Development

MPI Research today announced it has acquired the assets of Kalamazoo, Mich.-based Jasper Clinical Research & Development, Inc. Jasper is a respected clinical research organization that provides early-stage human clinical testing of promising new drugs, and is well known to pharmaceutical and biotechnology companies worldwide. [More]

Vancive and Aspen Medical partner to distribute absorbent wound dressing products in the UK, Ireland

Vancive Medical Technologies and Aspen Medical Europe Ltd. today announced an agreement for the exclusive distribution of the Vancive BeneHold Absorbent Wound Dressing portfolio in the United Kingdom and Ireland. [More]
Oncolytics signs equity distribution agreement with Canaccord Genuity

Oncolytics signs equity distribution agreement with Canaccord Genuity

Oncolytics Biotech Inc. announced today that it has entered into an "at-the-market" (ATM) equity distribution agreement with Canaccord Genuity Inc. acting as sole agent. [More]
Aseptika selected for Discovery Start-Ups 2014 award

Aseptika selected for Discovery Start-Ups 2014 award

Aseptika Limited was selected as one of five winners out of the eighteen strong field of UK start-up companies pitching for the winning prizes at the Discovery Start-Ups 2014 event held on Wednesday, 22nd October at Deloitte’s in London. [More]